News | November 23, 2023
Lupin launches Vilfuro-G for COPD Management in India
Lupin Vilfuro-G is the only FDC that uniquely combines Vilanterol, Fluticasone Furoate and Glycopyrronium Bromide
Lupin Vilfuro-G is the only FDC that uniquely combines Vilanterol, Fluticasone Furoate and Glycopyrronium Bromide
Evinova will operate as a separate health-tech business within AstraZeneca
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
India has the highest prevalence of diabetes globally, with an estimated 77 million people living with the condition and an expected 134 million cases by 2045
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
30 beneficiaries avail of services per minute
Lupin has been exclusively marketing these brands in the Indian market since July 2021
Apollo Telehealth has established more than 700 centers, in 7 states
Subscribe To Our Newsletter & Stay Updated
